Screening mammography beginning at age 40 years: A reappraisal of cost- effectiveness

Cancer

Volumn 82, Issue 11, 1998, Pages 2235-2240

  Rosenquist, C John ^a,b   Lindfors, Karen K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast; Carcinoma; Cost effectiveness; Mammography; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE POLICY; HUMAN; MAMMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED;

EID: 0032103495     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980601)82:11<2235::AID-CNCR19>3.0.CO;2-V     Document Type: Article

References (25)

1. Hendrick RE, Smith RA, Rutledge JH, Smart CR. Benefit of screening mammography in women aged 40-49 years. A new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst 1997;22:87-92.
2. Report of the organizing committee and collaborators, Falun Meeting. Falun, Sweden. March 21-22, 1996. Breast cancer screening with mammography in women aged 40-49 years. Int J Cancer 1996;68:693-9.
3. Bjurstam N, Bjorneld L, Duffy SW, Smith TC, Cahlin E, Erikson O. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49. Monogr Natl Cancer Inst 1997;22:53-5.
4. Lindfors KK, Rosenquist CJ. Needle core biopsy guided with mammography: a study of cost-effectiveness. Radiology 1994;190:217-22.
5. Bassett LW, Liu TH, Giuliano AE, Gold RH. The prevalence of carcinoma in palpable vs. impalpable, mammographically detected lesions. AJR Am J Roentgenol 1991;157:21-4.
6. Baker LH. Breast cancer detection demonstration project: five-year summary report. CA Cancer J Clin 1982;32:194-225.
7. Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology 1991;179:463-8.
8. Costanza ME. Breast cancer screening in older women. Cancer 1992;69(Suppl):1925-31.
9. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Likelihood ratios for modern screening mammography: risk of breast cancer based on age and mammographic interpretation. JAMA 1996;276:39-43.
10. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1993;270:2444-50.
11. Kopans DB, Moore RH, McCarthy KA, Hall DA, Hulka CA, Whitman GJ, et al. Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years. Radiology 1996;200:357-60.
12. Linver M. Screening pre and post menopausal women: outcome data from New Mexico. American Cancer Society workshop on guidelines for breast cancer detection. Atlanta: American Cancer Society, 1997.
13. Colditz GA, Willett WC, Hunter DJ, Stampfer MJ, Manson JE, Hennekens CH, et al. Family history, age, and risk of breast cancer: prospective data from the nurses' health study. JAMA 1993;270:338-43.
14. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk: the Utah population database. JAMA 1993;270:1563-8.
15. Leitch AM, Dodd GD, Costanza M, Linver M, Pressman P, McGinnis L, et al. American Cancer Society guidelines for the early detection of breast cancer, update 1997. CA Cancer J Clin 1997;47:150-3.
16. U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd edition. Baltimore: Williams and Wilkins, 1996:73.
17. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, et al. Five-hundred life saving interventions and their cost-effectiveness. Risk Anal 1995;15:369-90.
18. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-8.
19. Rosenquist CJ, Lindfors KK. Screening mammography in women aged 40-49 years: analysis of cost-effectiveness. Radiology 1994;191:647-50.
20. DeKoning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JC, Hubertine JA, Hendriks JH. Breast cancer screening and cost-effectiveness: policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 1991;49:531-7.
21. Hall J, Gerard K, Salkeld G, Richardson J. A cost utility analysis of mammography screening in Australia. Soc Sci Med 1992;34:993-1004.
22. Forrest P. Breast cancer screening: report to the health ministers of England, Wales, Scotland and Northern Ireland. London: Department of Health and Social Security, 1986.
23. Parker SH, Lovin JD, Jobe WE, Luethke JM, Hopper KD, Yakes WF, et al. Stereotactic breast biopsy with a biopsy gun. Radiology 1990;176:741-7.
24. Schmidt R, Morrow M, Bibbo M, Cox S. Benefits of stereotactic aspiration cytology. Admin Radiol 1990;9:35-42.
25. Eddy DM, Hasselmad V, McGivney W, Hendu W. The value of mammography screening in women under age 50 years. JAMA 1988;259:1512-9.